Rep68 protein of adeno-associated virus type 2 interacts with 14-3-3 proteins depending on phosphorylation at serine 535. (Q40581778)

21 September 2017

title

Rep68 protein of adeno-associated virus type 2 interacts with 14-3-3 proteins depending on phosphorylation at serine 535. (English)

1 reference

21 September 2017

1 reference

Song-Iee Han

1

1 reference

21 September 2017

Masa-Aki Kawano

2

1 reference

21 September 2017

Ken-Ichiro Ishizu

3

1 reference

21 September 2017

Hajime Watanabe

4

1 reference

21 September 2017

Makoto Hasegawa

5

1 reference

21 September 2017

Shin-Nosuke Kanesashi

6

1 reference

21 September 2017

Yang-Su Kim

7

1 reference

21 September 2017

Akira Nakanishi

8

1 reference

21 September 2017

Kohsuke Kataoka

9

1 reference

21 September 2017

Hiroshi Handa

10

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

21 September 2017

1 reference

21 September 2017

volume

320

1 reference

21 September 2017

issue

1

1 reference

21 September 2017

page(s)

144-155

1 reference

Dual level inhibition of E2F-1 activity by adeno-associated virus Rep78.

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.024

The cytoplasmic domain of the platelet glycoprotein Ibalpha is phosphorylated at serine 609.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.024

Mechanism of Rep-mediated adeno-associated virus origin nicking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.024

Mutagenesis of an AUG codon in the adeno-associated virus rep gene: effects on viral DNA replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.024

Phosphorylation of the adeno-associated virus replication proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.024

High mobility group chromosomal protein 1 binds to the adeno-associated virus replication protein (Rep) and promotes Rep-mediated site-specific cleavage of DNA, ATPase activity and transcriptional repression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.024

Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.024

PKA/PrKX activity is a modulator of AAV/adenovirus interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.024

14-3-3 proteins: structure, function, and regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.024

Selective extraction of polyoma DNA from infected mouse cell cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.024

Chimeric virus-like particle formation of adeno-associated virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.024

The AAV origin binding protein Rep68 is an ATP-dependent site-specific endonuclease with DNA helicase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.024

Roles of disulfide linkage and calcium ion-mediated interactions in assembly and disassembly of virus-like particles composed of simian virus 40 VP1 capsid protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.024

Isoforms of 14-3-3 protein can form homo- and heterodimers in vivo and in vitro: implications for function as adapter proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.024

DNA helicase-mediated packaging of adeno-associated virus type 2 genomes into preformed capsids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.024

Modulation of human DNA topoisomerase IIalpha function by interaction with 14-3-3epsilon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.024

Cloning of infectious adeno-associated virus genomes in bacterial plasmids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.024

The recombination signals for adeno-associated virus site-specific integration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.024

Site-specific integration by adeno-associated virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.024

Targeted integration of adeno-associated virus (AAV) into human chromosome 19

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.024

Inhibition of S-phase progression by adeno-associated virus Rep78 protein is mediated by hypophosphorylated pRb

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.024

High-performance affinity beads for identifying drug receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.024

Functional interactions of transcription factor human GA-binding protein subunits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.024

14-3-3 proteins: key regulators of cell division, signalling and apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.024

Copurification of casein kinase II with transcription factor ATF/E4TF3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.024

ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.024

Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.024

The structural basis for 14-3-3:phosphopeptide binding specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.024

Roles of adeno-associated virus Rep protein and human chromosome 19 in site-specific recombination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.024

Interaction of the adeno-associated virus Rep protein with a sequence within the A palindrome of the viral terminal repeat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.024

Infection of primary cells by adeno-associated virus type 2 results in a modulation of cell cycle-regulating proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.024

7 January 2021

The cellular transcription factor SP1 and an unknown cellular protein are required to mediate Rep protein activation of the adeno-associated virus p19 promoter.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.024

7 January 2021

The adeno-associated virus (AAV) Rep protein acts as both a repressor and an activator to regulate AAV transcription during a productive infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.024

7 January 2021

Sequence requirements for binding of Rep68 to the adeno-associated virus terminal repeats

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.024

7 January 2021

Mutational analysis of the adeno-associated virus Rep68 protein: identification of critical residues necessary for site-specific endonuclease activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.024

7 January 2021

Rescue and autonomous replication of adeno-associated virus type 2 genomes containing Rep-binding site mutations in the viral p5 promoter

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.024

7 January 2021

Factors affecting the terminal resolution site endonuclease, helicase, and ATPase activities of adeno-associated virus type 2 Rep proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.024

7 January 2021

10.1016/J.VIROL.2003.11.024

Identifiers

DOI

1 reference

21 September 2017

1 reference